Sarissa Capital Management LP
GREENWICH, CT · CIK 1577524 · 13F filing filed 2022-08-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyGreenwich, CT
$993.5m
reported value
-6.1% vs Q1 2022
11positions
100.0%in top 10
1 new
0 added
3 reduced
1 sold out
vs Q1 2022
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ALKERMES PLC ALKS | $418.3m42.10% | Unchanged |
| IRONWOOD PHARMACEUTICALS INC IRWD | $189.0m19.02% | Unchanged |
| BIOGEN INC BIIB | $131.1m13.20% | Unchanged |
| INNOVIVA INC INVA | $97.6m9.83% | Unchanged |
| GILEAD SCIENCES INC GILD | $82.9m8.35% | Reduced -221.0k |
| AMARIN CORP PLC SPONS ADR NEW | $35.8m3.60% | Reduced -2.0k |
| MERSANA THERAPEUTICS INC COM | $19.9m2.00% | Unchanged |
| BIOCRYST PHARMACEUTICALS INC BCRX | $14.7m1.48% | Unchanged |
| VOR BIOPHARMA INC COM | $3.1m0.31% | Reduced -89.0k |
| PEAR THERAPEUTICS INC CLASS A COM | $771.0k0.08% | Unchanged |
| REGULUS THERAPEUTICS INC RGLS | $383.0k0.04% | New |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| REGULUS THERAPEUTICS INC RGLS | $552.0k1.9m shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| AMARIN CORP PLC 13D · filed 2026-08-27 | 6.1% |
| IRONWOOD PHARMACEUTICALS INC IRWD · 13D · filed 2026-03-19 | 5.8%≈ $39.8m |